RT Journal Article
SR Electronic
T1 Iritis, glaucoma and corneal decompensation associated with BrightOcular cosmetic iris implant
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 1098
OP 1101
DO 10.1136/bjophthalmol-2015-307295
VO 100
IS 8
A1 Ahmad M Mansour
A1 Iqbal Ike K Ahmed
A1 Brennan Eadie
A1 Elias Chelala
A1 Joanna S Saade
A1 Stephen G Slade
A1 Ali A Mearza
A1 Dipak Parmar
A1 Marwan Ghabra
A1 Sheila Luk
A1 Alla Kelly
A1 Stephen C Kaufman
YR 2016
UL http://bjo.bmj.com/content/100/8/1098.abstract
AB Purpose NewColorIris cosmetic iris implants have a record of high ocular morbidity and are no longer in use. Newer generation of iris implants, BrightOcular, have patented posterior grooves in order to decrease iris touch and facilitate aqueous flow around the implant. However, little is known about their safety despite their implantations in 10 countries.Methods Collaborative case series of patients who had bilateral implantation of cosmetic iris implants solely for cosmetic reasons.Results 12 cases were collected being distributed as Caucasian (10) and Asian (2), women (11) and man (1) and with a mean age of 32 years. Ocular manifestations were present in 11 subjects and included anterior uveitis (10 of 12; 83.3%), glaucoma (7 of 12; 58.3%) and corneal decompensation (6 of 12; 50%). Visual acuity was normal in seven, decreased in five with two having visual recovery following explantation of the implant. Glaucoma could not be controlled medically in two patients.Conclusions Cosmetic iris implants carry the risk of ocular damage when implanted in the anterior chamber of normal phakic eyes.